id: nonselective_beta_blocker_access_to_hepatic_decompensation
name: Non-selective Beta-blocker Access â†’ Hepatic Decompensation
from_node:
  node_id: nonselective_beta_blocker_access
  node_name: Non-selective Beta-blocker Access
to_node:
  node_id: hepatic_decompensation
  node_name: Hepatic Decompensation
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Non-selective beta-blockers reduce portal pressure by decreasing cardiac
  output and splanchnic vasoconstriction'
- 'Step 2: Reduced portal pressure decreases risk of variceal development and bleeding'
- 'Step 3: Prevention of variceal hemorrhage reduces acute decompensation events'
- 'Step 4: Sustained portal pressure reduction may slow overall cirrhosis progression
  and decompensation risk'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Seohyuk Lee and Saad Saffo 2023. "Evolution of care in cirrhosis:
    Preventing hepatic decompensation through pharmacotherapy." *World Journal of
    Gastroenterology*. https://doi.org/10.3748/wjg.v29.i1.61'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.367194'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
